Cancer Cell

杂志介绍

Cancer Cell杂志介绍

《Cancer Cell》是一本以English为主的未开放获取国际优秀期刊，中文名称癌细胞，本刊主要出版、报道医学-CELL BIOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为48.8，最新CiteScore 指数为55.2。

本刊近期中国学者发表的论文主要有：

• Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer

  Author: Teng, Huajing; Wang, Yan; Sui, Xin; Fan, Jiawen; Li, Shuai; Lei, Xiao; Shi, Chen; Sun, Wei; Song, Maxiaowei; Wang, Hongzhi; Dong, Dezuo; Geng, Jianhao; Zhang, Yangzi; Zhu, Xianggao; Cai, Yong; Li, Yongheng; Li, Bo; Min, Qingjie; Wang, Weihu; Zhan, Qimin

• A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK

  Author: Xiaodong Feng, Nadia Arang, Damiano Cosimo Rigiracciolo, Joo Sang Lee, Huwate Yeerna, Zhiyong Wang, Simone Lubrano, Ayush Kishore, Jonathan A. Pachter, Gabriele M. König, Marcello Maggiolini, Evi Kostenis, David D. Schlaepfer, Pablo Tamayo, Qianming Chen, Eytan Ruppin, J. Silvio Gutkind

• Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation

  Author: Jinchul Kim, Lili Yu, Wancheng Chen, Yanxia Xu, Meng Wu, Dilyana Todorova, Qingshuang Tang, Bingbing Feng, Lei Jiang, Jingjin He, Guihua Chen, Xuemei Fu, Yang Xu

• CHAF1B Overexpression: A Brake for the Differentiation of Leukemia Cells

  Author: Qing Li, Xu Zhang, Zhiguo Zhang

英文介绍

Cancer Cell杂志英文介绍

Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.